bullish

Remegen

RemeGen (9995 HK) - Awaiting the Fruition of Overseas BD Collaborations

253 Views02 Apr 2024 20:08
Broker
RemeGen recorded RMB1.08bn of revenue in FY23, including RMB1.05bn from product sales (+42% YoY), contributed equally by RC18 and RC48.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 12-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
CMB International
External broker reports(aggregated public sources)
CMB International
China & Hong KongEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • RemeGen (9995 HK) - Awaiting the Fruition of Overseas BD Collaborations
    02 Apr 2024
x